“‘SALIVARY INTERLEUKIN-6 AS A BIOMARKER OF COVID-19 SEVERITY’” (2023) Academicia Globe: Inderscience Research, 4(02), pp. 45–52. doi:10.17605/OSF.IO/24H87.